STAT1 and neoplasm: This represents a major gap in our knowledge of STAT1 activation by HNSCC cells in the tumour microenvironment, which is essential to advance our mechanistic understanding of the role of STAT1 in HNSCC, and design therapies that exploit the STAT1 pathway in HNSCC treatment.